Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Genetic diversity and molecular mechanisms in hypertrophic cardiomyopathy: toward personalized therapy.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 28, 2026
Editorial: The newer paradigms in hypertension research and management.
Journal: Frontiers in medicine
Published: January 05, 2026
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.
Journal: Drugs - real world outcomes
Published: May 19, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI.
Journal: European journal of heart failure
Published: February 15, 2024
Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
Journal: Annals of internal medicine
Published: September 04, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI.
Journal: Journal of the American Heart Association
Published: August 23, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Journal: European journal of heart failure
Published: June 02, 2023
Editorial: Strategies for improving hypertension management.
Journal: Frontiers in medicine
Published: August 04, 2022
The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction.
Journal: Contemporary clinical trials
Published: March 08, 2022
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction.
Journal: Circulation. Cardiovascular quality and outcomes
Published: September 01, 2021
National Trends in the Use of Sacubitril/Valsartan.
Journal: Journal of cardiac failure
Published: January 30, 2021
Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System.
Journal: Pharmacotherapy
Published: September 10, 2019
Last Updated: 09/26/2026